Hypoxic preconditioning protects against ischemic brain injury
暂无分享,去创建一个
Myriam Bernaudin | M. Bernaudin | F. Sharp | A. Lu | R. Ran | Yang Tang | K. Strauss | Todd F. Glass | T. Ardizzone | Frank R. Sharp | Ruiqiong Ran | Aigang Lu | Yang Tang | Kenneth I. Strauss | Todd Glass | Tim Ardizzone | Ruiqiong Ran
[1] N. Maulik,et al. Hypoxia/reoxygenation promotes myocardial angiogenesis via an NF kappa B-dependent mechanism in a rat model of chronic myocardial infarction. , 2001, Journal of molecular and cellular cardiology.
[2] P. Ratcliffe,et al. New insights into an enigmatic tumour suppressor , 2003, Nature Cell Biology.
[3] P Ghezzi,et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Ivan,et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.
[5] D. Klimanis,et al. TNF-α–Induced Tolerance to Ischemic Injury Involves Differential Control of NF-κB Transactivation: The Role of NF-κB Association with p300 Adaptor , 2002 .
[6] M. Bernaudin,et al. Brain Genomic Response following Hypoxia and Re-oxygenation in the Neonatal Rat , 2002, The Journal of Biological Chemistry.
[7] Pietro Ghezzi,et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Ratcliffe,et al. Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.
[9] K. N. Dudkin,et al. The Adaptive Effects of Hypoxic Preconditioning of Brain Neurons , 2004, Neuroscience and Behavioral Physiology.
[10] K. S. Lee,et al. Ischemic tolerance in the rat neocortex following hypothermic preconditioning. , 2000, Journal of neurosurgery.
[11] E. Kaptanoğlu,et al. Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain , 2002, Child's Nervous System.
[12] J. Engelhardt,et al. Tyrosine Phosphorylation of IκBα Activates NFκB through a Redox-regulated and c-Src-dependent Mechanism Following Hypoxia/Reoxygenation* , 2003, The Journal of Biological Chemistry.
[13] Michael I. Wilson,et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.
[14] J. Caro,et al. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: Role of hypoxia responsive element , 2000, Molecular and Cellular Biochemistry.
[15] G. Lu,et al. Changes of Adenosine and Its A1 Receptor in Hypoxic Preconditioning , 1999, Neurosignals.
[16] L. Huang,et al. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway , 1998 .
[17] L. Neckers,et al. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. , 2003, The Biochemical journal.
[18] G. Semenza,et al. Induction of hypoxia‐inducible factor‐1 (HIF‐1) and its target genes following focal ischaemia in rat brain , 1999, The European journal of neuroscience.
[19] T. Kirino. Ischemic Tolerance , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Huang,et al. Hypoxia-inducible Factor and Its Biomedical Relevance* , 2003, Journal of Biological Chemistry.
[22] Stuart A. Lipton,et al. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.
[23] P. Carmeliet,et al. Hypoxia-inducible Factor-2α (HIF-2α) Is Involved in the Apoptotic Response to Hypoglycemia but Not to Hypoxia* , 2001, The Journal of Biological Chemistry.
[24] G. Semenza,et al. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.
[25] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[26] D. Gozal,et al. Excitotoxic preconditioning elicited by both glutamate and hypoxia and abolished by lactate transport inhibition in rat hippocampal slices , 2001, Neuroscience Letters.
[27] P. Ratcliffe,et al. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. , 1998, The Journal of experimental biology.
[28] S. Brooke,et al. Neuroprotective effects of an adenoviral vector expressing the glucose transporter: a detailed description of the mediating cellular events , 2001, Brain Research.
[29] Ç. Ulukuş,et al. Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats , 2003, Neonatology.
[30] Nigel Mackman,et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.
[31] R. Keep,et al. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? , 2002, Journal of neurochemistry.
[32] L. Neckers,et al. Microtubule Disruption Utilizes an NFκB-dependent Pathway to Stabilize HIF-1α Protein* , 2003, The Journal of Biological Chemistry.
[33] Masafumi Tagaya,et al. ‘Ischemic tolerance’ phenomenon detected in various brain regions , 1991, Brain Research.
[34] M. O'Neill,et al. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. , 1999, European journal of pharmacology.
[35] A. Bauer,et al. Regulation of tyrosine hydroxylase promoter activity by the von Hippel–Lindau tumor suppressor protein and hypoxia‐inducible transcription factors , 2003, Journal of neurochemistry.
[36] Andrew L. Kung,et al. Suppression of tumor growth through disruption of hypoxia-inducible transcription , 2000, Nature Medicine.
[37] J. Elkins,et al. Structure of Factor-inhibiting Hypoxia-inducible Factor (HIF) Reveals Mechanism of Oxidative Modification of HIF-1α* , 2003, The Journal of Biological Chemistry.
[38] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[39] S. Bhattacharya,et al. An essential role for p300/CBP in the cellular response to hypoxia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] K. Shirato,et al. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. , 2001, Biochemical and biophysical research communications.
[41] S. Antonarakis,et al. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[42] F. Sharp,et al. Multiple Molecular Penumbras after Focal Cerebral Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[43] D. Klimanis,et al. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma , 2001, Brain Research.
[44] G. Lu,et al. Downregulation of nitric oxide in the brain of mice during their hypoxic preconditioning. , 2001, Journal of applied physiology.
[45] P. Ratcliffe,et al. Oxygen sensors and angiogenesis. , 2002, Seminars in cell & developmental biology.
[46] S. Kourembanas,et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. , 1995, Circulation research.
[47] T Kobayashi,et al. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. , 2001, Genes & development.
[48] P. Carmeliet,et al. Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (vol 394, pg 485, 1998) , 1998 .
[49] D. Ferriero,et al. Hypoxia-Ischemia, but Not Hypoxia Alone, Induces the Expression of Heme Oxygenase-1 (HSP32) in Newborn Rat Brain , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[50] E. Mackenzie,et al. A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[51] B. Zbar,et al. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. , 1999, The Journal of clinical investigation.
[52] R. Mentzer,et al. Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. , 1993, Cardiovascular research.
[53] P. Ratcliffe,et al. Hypoxia response elements. , 1997, Oncology research.
[54] S. Nelson,et al. Hypoxia preconditioning attenuates brain edema associated with kainic acid-induced status epilepticus in rats , 1999, Brain Research.
[55] A. Buchan,et al. Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia , 1999, Neurology.
[56] G. Semenza,et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.
[57] R. Jaenisch,et al. HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.
[58] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[59] F. Sharp,et al. Blood Genomic Expression Profile for Neuronal Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[60] A. Koong,et al. Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.
[61] E. Morishita,et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[62] S. L. Fink,et al. An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid , 2000, Brain Research.
[63] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[64] G. Semenza,et al. Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.
[65] A. Rizzino,et al. Stimulation of the murine type II transforming growth factor‐β receptor promoter by the transcription factor Egr‐1 , 2002, Molecular reproduction and development.
[66] F. Squadrito,et al. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. , 2002, European journal of pharmacology.
[67] U. Dirnagl,et al. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons , 1998, Neuroscience Letters.
[68] T. Collins,et al. Extinguishing Egr‐1‐dependent inflammatory and thrombotic cascades following lung transplantation , 2001 .
[69] G. Semenza,et al. Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.
[70] M. Ivan,et al. The von Hippel-Lindau tumor suppressor protein. , 2001, Current opinion in genetics & development.
[71] T. Purshottam,et al. Hypoxia tolerance in rats in relation to tissue glycogen levels. , 1978, Aviation Space and Environmental Medicine.
[72] P. Ratcliffe,et al. The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma , 2001, Oncogene.
[73] A. Shah,et al. Nitric Oxide Mediates Cerebral Ischemic Tolerance in a Neonatal Rat Model of Hypoxic Preconditioning , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[74] M. Ivan,et al. Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.
[75] W. Kaelin,et al. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. , 1998, Genes & development.
[76] G. Semenza,et al. Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[77] 啓明 佐々木. Hypoxia/reoxygenation promotes myocardial angiogenesis via an NFκB-dependent mechanism in a rat model of chronic myocardial infarction , 2003 .
[78] R. Mallet,et al. Hypoxic preconditioning attenuates stunning caused by repeated coronary artery occlusions in dog heart. , 1993, Cardiovascular research.
[79] M. Lazdunski,et al. Activation of the Nuclear Factor-κB Is a Key Event in Brain Tolerance , 2001, The Journal of Neuroscience.
[80] P. Stanton,et al. Hypoxia triggers neuroprotective alterations in hippocampal gene expression via a heme-containing sensor , 1996, Brain Research.
[81] Christopher J Schofield,et al. Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family* , 2002, The Journal of Biological Chemistry.
[82] 貞本 泰孝. Erythropoietin Prevents Place Navigation Disability and Cortical Infarction in Rats with Permanent Occlusion of the Middle Cerebral Artery , 2000 .
[83] M. Krug,et al. The importance of free hydroxyl radicals to hypoxia preconditioning , 2000, Brain Research.
[84] K. Jungermann,et al. Cross-talk between the signals hypoxia and glucose at the glucose response element of the L-type pyruvate kinase gene. , 2001, Endocrinology.
[85] G. Zhao,et al. Tissue plasminogen activator protects hippocampal neurons from oxygen‐glucose deprivation injury , 2001, Journal of neuroscience research.
[86] G. Semenza,et al. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.
[87] Christopher J. Schofield,et al. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL , 2002, Nature.
[88] K. Jungermann,et al. Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. , 2003, Blood.
[89] W. Kaelin,et al. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[90] F. Sharp. Stress genes protect brain , 1998, Annals of neurology.
[91] R. Currie,et al. Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27 , 2000, Brain Research.
[92] A. Shah,et al. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat , 1994, Neuroscience Letters.
[93] Ding-I Yang,et al. iNOS expression inhibits hypoxia-inducible factor-1 activity. , 2000, Biochemical and biophysical research communications.
[94] P. Ratcliffe,et al. Regulation of HIF by the von Hippel‐Lindau Tumour Suppressor: Implications for Cellular Oxygen Sensing , 2001, IUBMB life.
[95] F. Sharp,et al. The stress gene response in brain. , 1996, Cerebrovascular and brain metabolism reviews.
[96] F. Samson,et al. Effects of hypoxia preconditioning on expression of metallothionein-1,2 and heme oxygenase-1 before and after kainic acid-induced seizures. , 2000, Cellular and molecular biology.
[97] U. Dirnagl,et al. Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism? , 2002, Neuroreport.
[98] R. Simon,et al. Ischemic tolerance in the brain , 1997, Neurology.
[99] H. Nakase,et al. Increased Hypoxic Tolerance by Chemical Inhibition of Oxidative Phosphorylation: “Chemical Preconditioning” , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[100] L. Neckers,et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1α , 1998, Nature.
[101] Jan Neckář,et al. Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive , 2001, Basic Research in Cardiology.
[102] R. Sapolsky,et al. Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[103] Brandon A. Miller,et al. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion , 2001, Neuroreport.
[104] G. Semenza,et al. Role of hypoxia‐inducible factor‐1 in hypoxia‐induced ischemic tolerance in neonatal rat brain , 2000, Annals of neurology.
[105] Y. Zou,et al. Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.
[106] R. Currie,et al. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. , 1998, Stroke.
[107] S. Tsirka. Tissue plasminogen activator as a modulator of neuronal survival and function. , 2001, Biochemical Society transactions.
[108] H. Zhu,et al. Signal transduction. How do cells sense oxygen? , 2001, Science.
[109] A. Cerami,et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[110] T. Sick,et al. Anoxic preconditioning in hippocampal slices: role of adenosine , 1996, Neuroscience.
[111] B. Aronow,et al. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia , 2002, The European journal of neuroscience.
[112] F R Sharp,et al. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: Blood genomic fingerprints of disease , 2001, Annals of neurology.
[113] W. Makałowski,et al. Hypoxia induces mitochondrial DNA damage and stimulates expression of a DNA repair enzyme, the Escherichia coli MutY DNA glycosylase homolog (MYH), in vivo, in the rat brain , 2002, Journal of neurochemistry.
[114] M. Bernaudin,et al. Hypoxia-inducible factor in brain. , 2001, Advances in experimental medicine and biology.
[115] E. Jacobsohn,et al. Ischaemic preconditioning: mechanisms and potential clinical applications , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[116] K. Jungermann,et al. Signaling cross-talk between hypoxia and glucose via hypoxia-inducible factor 1 and glucose response elements. , 2002, Biochemical pharmacology.
[117] Eamonn R. Maher,et al. Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* , 2000, The Journal of Biological Chemistry.
[118] R. Vannucci,et al. Hypoxic Preconditioning Increases Brain Glycogen and Delays Energy Depletion from Hypoxia-Ischemia in the Immature Rat , 2003, Developmental Neuroscience.
[119] U. Dirnagl,et al. Desferrioxamine Induces Delayed Tolerance against Cerebral Ischemia in Vivo and in Vitro , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[120] M. Buemi,et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection. , 2002, Clinical science.
[121] U. Dirnagl,et al. Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model , 2002, The Journal of Neuroscience.
[122] P. Ratcliffe,et al. Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor* , 2001, The Journal of Biological Chemistry.
[123] J. Hallenbeck,et al. Cell Permeable Exogenous Ceramide Reduces Infarct Size in Spontaneously Hypertensive Rats Supporting In Vitro Studies That Have Implicated Ceramide in Induction of Tolerance to Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[124] D. Livingston,et al. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[125] Chemical preconditioning: A cytoprotective strategy , 1997 .
[126] M. Bennett,et al. Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampal CA1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[127] E. Englander,et al. Mitochondrial DNA damage and a hypoxic response are induced by CoCl(2) in rat neuronal PC12 cells. , 2000, Nucleic acids research.
[128] ChengXiang Zhai,et al. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[129] Kentaro Takahashi,et al. Von Hippel-Lindau Disease , 2024 .
[130] Weining Lu,et al. Cloning and functional analysis of the mouse 5-lipoxygenase promoter. , 2002, American journal of respiratory cell and molecular biology.
[131] R. Mallet,et al. Hypoxic preconditioning of ischaemic canine myocardium. , 1992, Cardiovascular research.
[132] Liliana Attisano,et al. Synergistic Cooperation between Hypoxia and Transforming Growth Factor-β Pathways on Human Vascular Endothelial Growth Factor Gene Expression* , 2001, The Journal of Biological Chemistry.
[133] J. Bryan,et al. Ischemic Preconditioning in the Hippocampus of a Knockout Mouse Lacking SUR1-Based KATP Channels , 2003, Stroke.
[134] T. Toyoda,et al. Hypothermia‐Induced Ischemic Tolerance , 1999, Annals of the New York Academy of Sciences.
[135] E. Mackenzie,et al. Normobaric Hypoxia Induces Tolerance to Focal Permanent Cerebral Ischemia in Association with an Increased Expression of Hypoxia-Inducible Factor-1 and its Target Genes, Erythropoietin and VEGF, in the Adult Mouse Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[136] Mircea Ivan,et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[137] M. Halterman,et al. Hypoxia-Inducible Factor-1α Mediates Hypoxia-Induced Delayed Neuronal Death That Involves p53 , 1999, The Journal of Neuroscience.
[138] K. Shimoji,et al. A forebrain ischemic preconditioning model established in C57Black/Crj6 mice , 2001, Journal of Neuroscience Methods.
[139] H. Bunn,et al. How Do Cells Sense Oxygen? , 2001, Science.
[140] Till Acker,et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.
[141] K. Reymann,et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[142] T. Fojo,et al. p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription* , 1998, The Journal of Biological Chemistry.
[143] J. Gidday,et al. Mouse models of retinal ischemic tolerance. , 2002, Investigative ophthalmology & visual science.
[144] M. Venkatachalam,et al. Gene promoter of apoptosis inhibitory protein IAP2: identification of enhancer elements and activation by severe hypoxia. , 2002, The Biochemical journal.
[145] T. Kawamoto,et al. Identification of Functional Hypoxia Response Elements in the Promoter Region of the DEC1 and DEC2 Genes* , 2002, The Journal of Biological Chemistry.
[146] M. Braddock,et al. Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[147] R. Vannucci,et al. Hypoxic Preconditioning and Hypoxic‐Ischemic Brain Damage in the Immature Rat: Pathologic and Metabolic Correlates , 1998, Journal of neurochemistry.
[148] D. Epner,et al. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. , 2002, Biochimica et biophysica acta.
[149] M. Bernaudin,et al. Glial expression of heat shock proteins (HSPs) and oxygen-regulated proteins (ORPs). , 2001, Progress in brain research.
[150] S. Nelson,et al. A global hypoxia preconditioning model: neuroprotection against seizure-induced specific gravity changes (edema) and brain damage in rats. , 1999, Brain research. Brain research protocols.
[151] Y. Yuan,et al. Gene regulation during hypoxia in excitable oxygen-sensing cells: depolarization-transcription coupling. , 2000, Advances in experimental medicine and biology.
[152] S. Lipton,et al. Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.
[153] R. Simon,et al. Stress Proteins and Tolerance to Focal Cerebral Ischemia , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[154] L. Bianchi,et al. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. , 1999, Nucleic acids research.
[155] G. Yancopoulos,et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. , 2002, The Journal of clinical investigation.
[156] M. Marber,et al. Hypoxic preconditioning of ischaemic myocardium. , 1992, Cardiovascular research.
[157] R. Auer,et al. Hypoxia, hyperoxia, ischemia, and brain necrosis , 2000, Neurology.
[158] F. Tomasello,et al. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. , 2000, European journal of pharmacology.
[159] A. Lochner,et al. Preconditioning with hypoxia versus global ischemia in the isolated rat heart: effect on function and metabolism. , 1994, Cardioscience.
[160] G. Semenza,et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. , 1994, The Journal of biological chemistry.
[161] D. Katayose,et al. Acute ischaemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischaemia. , 1994, Cardiovascular research.
[162] G. Greeley,et al. Rat MYH, a glycosylase for repair of oxidatively damaged DNA, has brain‐specific isoforms that localize to neuronal mitochondria , 2002, Journal of neurochemistry.
[163] N. Jones,et al. Hypoxic Preconditioning Induces Changes in HIF-1 Target Genes in Neonatal Rat Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[164] G. Semenza. Angiogenesis in ischemic and neoplastic disorders. , 2003, Annual review of medicine.
[165] R. Simon. Hypoxia versus ischemia , 1999, Neurology.
[166] G. Greeley,et al. Hypoxia‐induced mitochondrial and nuclear DNA damage in the rat brain , 1999, Journal of neuroscience research.
[167] Mao-tsun Lin,et al. Chronic Hypoxia Preconditioning Increases Survival In Rats Suffering From Heatstroke , 2002, Clinical and experimental pharmacology & physiology.
[168] J. LaManna,et al. Activation of Hypoxia-Inducible Factor-1 in the Rat Cerebral Cortex after Transient Global Ischemia: Potential Role of Insulin-Like Growth Factor-1 , 2002, The Journal of Neuroscience.
[169] J. Dichgans,et al. Neuroprotection by Hypoxic Preconditioning Requires Sequential Activation of Vascular Endothelial Growth Factor Receptor and Akt , 2002, The Journal of Neuroscience.
[170] D M Stern,et al. A pathway leading to hypoxia-induced vascular fibrin deposition. , 2000, Seminars in thrombosis and hemostasis.
[171] G. Grasso,et al. Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. , 2001, Journal of neurosurgical sciences.
[172] P. Lewczuk,et al. Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.
[173] F. Sharp,et al. Cloning of rat grp75, an hsp70‐family member, and its expression in normal and ischemic brain , 1995, Journal of neuroscience research.
[174] Z. Kleinrok,et al. The role of opioid receptors in hypoxic preconditioning against seizures in brain , 2000, Pharmacology Biochemistry and Behavior.
[175] G. Semenza. Oxygen-regulated transcription factors and their role in pulmonary disease , 2000, Respiratory research.